By focusing on the p53 and NF-kB pathways, the chief elements of the cellular DDR, we reveal that gene induction in CDK12-inhibited cells is functionally important and a prerequisite for the increased sensitivity of cancer cells to P-TEFb inhibitors. The gene discussed is NFKB1; the disease is cancer.